$8.05 -0.36 (-4.28%)
11/27/2009 1:00 PM

NeurogesX, Inc. (NGSX)

CAPS Rating: 2 out of 5

A biopharmaceutical company, which focused on developing and commercializing novel pain management therapies.

Featured Broker Partners